Filing Details
- Accession Number:
- 0001570523-18-000010
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-29 20:34:50
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-29 20:34:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-05 | 5,000 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-07 | 975 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-07 | 10,025 | $0.17 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-12 | 2,000 | $0.18 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-12 | 5,000 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-13 | 1,000 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 500 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 500 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 1,000 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 500 | $0.22 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 200 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 400 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-15 | 300 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-19 | 5,000 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-19 | 2,000 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-20 | 5,000 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-20 | 500 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-20 | 100 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-20 | 100 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-21 | 17,500 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-21 | 500 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-25 | 200 | $0.21 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-25 | 1,250 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-25 | 250 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-25 | 1,000 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-25 | 1,000 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-26 | 500 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-26 | 1,000 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-26 | 1,000 | $0.20 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-27 | 300 | $0.19 | 20,800,359 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
